Ausgabe 4/2012
Inhalt (8 Artikel)
Embedding ‘Speaking Up’ into Systems for Safe Healthcare Product Development and Marketing Surveillance
Brian Edwards, Bruce Hugman, Mary Tobin, Matthew Whalen
Deriving Dose Limits for Warnings in Electronic Prescribing Systems
Jamie J. Coleman, James Hodson, Robin E. Ferner
Risk Minimization Activities of Centrally Authorized Products in the EU
Inge M. Zomerdijk, Fakhredin A. Sayed-Tabatabaei, Gianluca Trifirò, Stella C. F. Blackburn, Miriam C. J. M. Sturkenboom, Sabine M. J. M. Straus
Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones
Domenico Motola, Carlo Piccinni, Chiara Biagi, Emanuel Raschi, Anna Marra, Giulio Marchesini, Elisabetta Poluzzi
Assessing Opioid Shopping Behaviour
M. Soledad Cepeda, Daniel Fife, Wing Chow, Gregory Mastrogiovanni, Scott C. Henderson
Vaccine-Based Subgroup Analysis in VigiBase
Sandra de Bie, Katia M. C. Verhamme, Sabine M. J. M. Straus, Bruno H. Ch. Stricker, Miriam C. J. M. Sturkenboom